HitGen to develop novel class of drugs with MTPC

China based HitGen Inc. has announced that HitGen and Mitsubishi Tanabe Pharma Corporation (MTPC) have entered into a li...

December 19, 2019 | Thursday | News
OUE LIPPO to develop International Hospital in Prince Bay, China

OUE Lippo Healthcare Limited (“OUELH”), on 12 Dec 2019, announced that it has entered into a non-binding let...

December 18, 2019 | Wednesday | News
GE Healthcare, GDD invest $10M for bioprocess academy

GE Healthcare Life Sciences and the Guangzhou Development District Investment Promotion Bureau (GDD) have signed an agre...

December 5, 2019 | Thursday | News
CStone completes VOYAGER trial enrollment in Chinese patients

CStone Pharmaceuticals has announced that the on-going, global Phase III VOYAGER clinical trial of avapritinib, an inves...

December 16, 2019 | Monday | News
West China Hospital to build new hospital in Chengdu Tianfu New Area

West China Hospital of Sichuan University, a prestigious medical center located in Chengdu, Sichuan&...

December 11, 2019 | Wednesday | News
Ally Bridge Group finances 3 new Medtech investments with $140 M

Ally Bridge Group ("ABG"), a leading global life science investment group based in Hong Kong and New York, has announced...

December 16, 2019 | Monday | News
AT & IT China 2020 to showcase intelligent pharma solutions

AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of ...

December 13, 2019 | Friday | News
Avantor opens customer support centre in Shanghai

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and...

December 12, 2019 | Thursday | News
East China aims to develop life and health industry

Nanjing Jiangbei New Area, a state-level new area in East China's Jiangsu Province, is committed to building a...

December 11, 2019 | Wednesday | News
HitGen with Janssen to build novel DNA-Encoded Libraries

China based HitGen Inc. is pleased to announce that the company has entered into a strategic collaboration with Janssen ...

December 10, 2019 | Tuesday | News
AI biotech firm Zenerchi to penetrate within Asia

Life extension and biomedical simulation and visualization AI company US based Zenerchi and China based P...

December 9, 2019 | Monday | News
AstraZeneca receives Chinese marketing nod for Lynparza

AstraZeneca and MSD have announced that the companies have received marketing authorisation from China’s National ...

December 9, 2019 | Monday | News
Merck, Ping An Good Doctor to advance healthcare in China

Merck, a leading science and technology company, has signed a strategic collaboration agreement with one of the world's ...

December 5, 2019 | Thursday | News
Brii Biosciences expands focus to neurosciences

Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in Chi...

December 4, 2019 | Wednesday | News
CASI Pharma gets China approval Of CNCT19 Clinical Trial Applications

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therap...

December 4, 2019 | Wednesday | News
China NMPA accepts Lenvima for Additional Indication of Thyroid Cancer

Tokyo based Eisai Co., Ltd. has announced that LENVIMA (generic name: lenvatinib), the orally available kinase inhibitor...

December 4, 2019 | Wednesday | News
CMAB, Fapon join hands for biologic oncology asset

CMAB Biopharma Inc., a pure-play, biologics contract manufacturing and development organization (CDMO) and Shenzhen Fapo...

December 3, 2019 | Tuesday | News
ChainZ Medical integrates RADLogics™ Virtual Resident™ AI solution

RADLogics™ has announced that the China-based ChainZ Medical Technology Co. has selected the RADLogics Virtual Res...

December 2, 2019 | Monday | News